Shin Nippon Biomedical Laboratories Ltd  

(Public, TYO:2395)   Watch this stock  
Find more results for 2395
631.00
-4.00 (-0.63%)
Jul 29 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 617.00 - 640.00
52 week 300.00 - 853.00
Open 633.00
Vol. 483,800.00
Mkt cap 26.27B
P/E 10.73
Div/yield     -
EPS 58.81
Shares 41.63M
Beta     -
Inst. own     -
Aug 12, 2016
Q1 2017 Shin Nippon Biomedical Laboratories Ltd Earnings Release (Estimated) Add to calendar
Jun 29, 2016
Shin Nippon Biomedical Laboratories Ltd Annual Shareholders Meeting
Jun 24, 2016
Shin Nippon Biomedical Laboratories Ltd Annual Shareholders Meeting (Estimated)
May 13, 2016
Full Year 2016 Shin Nippon Biomedical Laboratories Ltd Earnings Release
  

Key stats and ratios

Q1 (Mar '16) 2016
Net profit margin -0.86% 17.95%
Operating margin -15.78% -13.65%
EBITD margin - -15.40%
Return on average assets -0.31% 5.96%
Return on average equity -0.91% 20.31%
Employees 1,630 -
CDP Score - -

Address

12F, St.Luke's Tower, 8-1, Akashi-cho
CHUO-KU, TKY 104-0044
Japan
+81-3-55655001 (Phone)
+81-3-55656160 (Fax)

Website links

Description

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.

Officers and directors

Ryoichi Nagata Chairman of the Board, President, Group Chief Executive Officer, Chairman of Subsidiary, Representative Director
Age: 57
Toshihiko Seki Vice Chairman of the Board, Global Chief Financial Officer, Representative Director
Age: 61
Koichiro Fukuzaki Vice Chairman of the Board
Age: 57
Takeshi Yamakawa Chief Executive Officer of Subsidiary, Director
Age: 49
Ken Takanashi Vice President, Director
Age: 52
Shuichi Kanazashi Managing Director, President of TR Business Company
Hidenobu Sameshima Managing Director, Director of Safety Research Institute
Age: 58
Hideyuki Hirama Executive Director
Age: 39
Shinji Nitanda Executive Director
Age: 47
Kazumi Uchi Executive Director
Age: 58